Tag: Imo

In a 2010 study published in the *Journal of Clinical Gastroenterology*, a combination of rifaximin (the active ingredient in Xifaxan) and neomycin demonstrated an 85% clinical response rate in treating irritable bowel syndrome patients who tested positive for methane on breath tests. This evidence supports the targeted use of these two antibiotics together for specific conditions, most notably Small Intestinal Bacterial Overgrowth (SIBO) where methanogens are present.

Studies have shown that combining rifaximin and neomycin can be effective in addressing intestinal methanogen overgrowth (IMO), with some research indicating a significantly higher rate of methane eradication compared to using either antibiotic alone. This article provides essential information on **how to take rifaximin and neomycin together**, but should never replace professional medical advice.